Update on the Use of Topical Calcineurin Inhibitors in Cutaneous Lupus Erythematosus

    February 2011 in “ Biologics: Targets & Therapy ”
    Michael Sticherling
    Image of study
    TLDR Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.
    The document from 2011 reviews the use of topical calcineurin inhibitors (TCIs), tacrolimus and pimecrolimus, in treating cutaneous lupus erythematosus (CLE). It compiles data from various small studies and case reports involving a total of 144 patients, showing that TCIs can be effective in treating CLE, particularly with 0.1% tacrolimus ointment. The effectiveness varies across CLE subsets, with systemic lupus erythematosus lesions responding well, while discoid lupus erythematosus lesions are less responsive. TCIs are well-tolerated with minimal side effects and do not cause skin atrophy, making them a promising alternative to corticosteroids. However, the document emphasizes the need for more extensive, controlled studies to establish evidence-based protocols for their use in CLE, as current clinical effects are limited to the duration of treatment. Concerns about the potential risk of skin malignancies with long-term use of TCIs are noted, but the document suggests that the risk may be overrated for CLE patients who follow strict UV protection guidelines.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Topical - Lantoprost .01%, MIN 10% DUT .05%, Hydrocortisone 1% Progrestron .025%

      in Treatment  6 upvotes 2 months ago
      A user was prescribed a topical treatment for hair loss including Latanoprost, Minoxidil, Dutasteride, Hydrocortisone, and Progesterone, after using an oral Minoxidil and Finasteride combo without significant results. Concerns were raised about the long-term use of hydrocortisone, with suggestions to consult a doctor regularly.

      community How come topical finasteride even works at all?

      in Finasteride/Dutasteride  31 upvotes 6 days ago
      Topical finasteride can effectively reduce scalp DHT by targeting local enzymes, despite less systemic impact compared to oral forms. Combining oral dutasteride with topical finasteride and minoxidil may enhance hair loss prevention, though evidence of its effectiveness is limited.

      community Topical melatonin spray to reduce hair shedding recommends?

      in Product  1 upvotes 1 week ago
      The user has been using topical melatonin spray with finasteride and dutasteride to reduce hair shedding but dislikes the lavender scent of their current spray. They are seeking recommendations for a scentless or better-smelling melatonin spray.

      community Topical Dutasteride Seems to Work

      in Research/Science  22 upvotes 1 week ago
      Topical dutasteride, particularly at 0.05%, shows greater hair density improvement than oral finasteride over 24 weeks, though hair thickness gains are similar. Some users report side effects with topical treatments, but others find them effective for maintaining hair without significant systemic absorption.

    Similar Research

    5 / 1000+ results